Anti-Smad2 + Smad3 antibody
Be the first to review this product! Submit a review
|
(14 Publications)
Rabbit Polyclonal SMAD3 antibody. Suitable for ICC/IF, Flow Cyt, WB and reacts with Human, Mouse, Rat samples. Cited in 14 publications. Immunogen corresponding to Synthetic Peptide within Human SMAD3 aa 1-100 conjugated to Keyhole Limpet Haemocyanin.
View Alternative Names
MADH3, SMAD3, Mothers against decapentaplegic homolog 3, MAD homolog 3, Mad3, Mothers against DPP homolog 3, hMAD-3, JV15-2, SMAD family member 3, SMAD 3, Smad3, hSMAD3
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-Smad2 + Smad3 antibody (AB217553)
Hela cell; 4% Paraformaldehyde-fixed; Triton X-100 at room temperature for 20 min; Blocking buffer (normal goat serum) at 37°C for 20 min; Antibody incubation with (Smad3) polyclonal Antibody, Unconjugated (ab217553) 1 : 100, 90 minutes at 37°C; followed by a conjugated Goat Anti-Rabbit IgG antibody at 37°C for 90 minutes, DAPI (blue) was used to stain the cell nuclei.
- Flow Cyt
Supplier Data
Flow Cytometry - Anti-Smad2 + Smad3 antibody (AB217553)
HUVEC cells(black) were fixed with 4% PFA for 10min at room temperature,permeabilized with 90% ice-cold methanol for 20 min at -20℃, and incubated in 5% BSA blocking buffer for 30 min at room temperature. Cells were then stained with Smad2/3 Polyclonal Antibody(ab217553) at 1 : 50 dilution in blocking buffer and incubated for 30 min at room temperature, washed twice with 2% BSA in PBS, followed by secondary antibody(blue) incubation for 40 min at room temperature. Acquisitions of 20,000 events were performed. Cells stained with primary antibody (green), and isotype control (orange).
- WB
Supplier Data
Western blot - Anti-Smad2 + Smad3 antibody (AB217553)
12% SDS-PAGE
All lanes:
Western blot - Anti-Smad2 + Smad3 antibody (ab217553) at 1/200 dilution
Lane 1:
mouse brain lysates
Lane 2:
mouse kidney lysates
Secondary
All lanes:
HRP-conjugated secondary antibody at 1/3000 dilution
Observed band size: 47 kDa
false
- WB
Supplier Data
Western blot - Anti-Smad2 + Smad3 antibody (AB217553)
All lanes:
Western blot - Anti-Smad2 + Smad3 antibody (ab217553) at 1/1000 dilution
Lane 1:
Mouse cerebrum lysate
Lane 2:
Mouse heart lysate
Lane 3:
Mouse testis lysate
Lane 4:
Mouse Skin lysate
Lane 5:
Mouse Kidney lysate
Lane 6:
Rat cerebrum lysate
Lane 7:
Rat Testis lysate
Lane 8:
Rat kidney lysate
Lane 9:
HUVEC cell lysate
Lane 10:
A459 cell lysate
Lane 11:
HeLa cell lysate
Lane 12:
HT1080 cell lysate
Lane 13:
A431 cell lysate
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The functions of Smad2 and Smad3 are critical in mediating cellular processes such as proliferation differentiation and apoptosis. These proteins often form complexes specifically oligomeric structures with other Smad proteins like co-Smad4 to exert their regulatory roles. The Smad2/3 complexes control the transcription of specific genes in response to TGF-β stimuli influencing cellular responses in a context-dependent manner.
Pathways
Smad2 and Smad3 are central to the TGF-β signaling pathway one significant pathway that affects cellular growth and differentiation. These proteins interact with TGF-β receptors on the cell surface to become phosphorylated forming a complex with Smad4 which then translocates to the nucleus. In the nucleus this complex regulates gene expression. Both Smad2 and Smad3 also engage with other signaling pathways such as the MAPK pathway further influencing cell behavior and cooperating with proteins like ERK.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (14)
Recent publications for all applications. Explore the full list and refine your search
BMC cancer 25:1313 PubMed40804612
2025
Applications
Unspecified application
Species
Unspecified reactive species
Theranostics 14:6185-6201 PubMed39431015
2024
Applications
Unspecified application
Species
Unspecified reactive species
British journal of pharmacology 181:1308-1323 PubMed37990806
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cellular & molecular biology letters 28:15 PubMed36849929
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of oral science 14:37 PubMed35853862
2022
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 24:251 PubMed35761941
2022
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 24:496 PubMed35837062
2022
Applications
Unspecified application
Species
Unspecified reactive species
Iranian journal of public health 50:1973-1982 PubMed35223564
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine (Cambridge, Mass.) 28:9 PubMed35090386
2022
Applications
Unspecified application
Species
Unspecified reactive species
Life sciences 229:261-276 PubMed31082400
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com